Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-11-18 FORBES CHRISTOPHER Director Grant or award · Common Stock Option (right to buy) +27,882 64,107
2014-11-18 FORBES CHRISTOPHER Director Grant or award · Common Stock Option (right to buy) +3,462 $0.42 $1K 67,569
2014-05-14 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +17,464 36,406
2013-09-13 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +318,000 2,002,193
2013-05-17 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +238,372 1,684,193
2013-02-19 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +89,016 1,495,821
2012-11-26 FORBES CHRISTOPHER Director Purchase +2,500 $0.16 $400 12,757,318
2012-11-16 FORBES CHRISTOPHER Director Grant or award · Common Stock Options +252,000 1,302,563
2012-11-16 FORBES CHRISTOPHER Director Grant or award · Common Stock Options +124,242 1,426,805
2012-08-08 FORBES CHRISTOPHER Director Conversion +4,292,583 $0.26 $1.1M 12,754,818
2012-08-08 FORBES CHRISTOPHER Director Conversion · Series B Convertible Preferred Stock −1,000 0
2012-05-16 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +35,366 1,050,563
2012-02-16 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +36,458 1,015,197
2012-01-06 FORBES CHRISTOPHER Director Purchase +192,308 $0.26 $50K 8,239,021
2011-11-16 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +87,500 1,018,739
2011-09-30 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +190,000 931,239
2011-05-17 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +37,962 741,239
2011-03-22 FORBES CHRISTOPHER Director Purchase +15,000 $0.28 $4K 7,452,289
2011-02-14 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +32,758 703,277
2010-11-17 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +125,000 603,211

Page 1 of 3 · 59 trades